CTVA changes
Pick any two versions below to diff them.
- Price
- $12.88 → $12.17(−5.5%)
- Next earnings
- Nov 11, 2026 → Nov 12, 2026
- Thesis
- The market prices Corteva at a discount because the company that remained after the spin-off holds the legacy PFAS liabilities of the old DuPont, and these liabilities have no clear limit. Fifteen US states and one sovereign sued on October 1, 2026 to challenge the spin-off. On October 9, a federal court in Indiana issued a temporary order that stopped dividends, buybacks and asset sales outside normal business, but the court stayed the order on October 10 while Corteva appeals to the Seventh Circuit. Crop chemicals also face price pressure from cheap generic products: Crop Protection prices fell 4% in Q2 2026, mainly in Latin America, and rival FMC cut its Q3 outlook sharply on October 15, 2026. For the gap to close, three things must be true. The Seventh Circuit must keep the order stayed or reverse it, and the states' case must end without an unwind of the spin-off or a large payment. PFAS costs must stay within the shared limits of the 2021 agreement, as in the North Carolina settlement of September 2026, where Corteva's share was about $66 million. Crop Protection sales and margins must hold against generic competition. The first evidence comes with the first report as a stand-alone company on November removed: 11, added: 12, 2026, and the appeal decision, expected in the next months. If the legal risk falls, the gap can close over 2027, but PFAS claims can take years to end.
- Balance sheet
- The latest reported balance sheet, at June 30, 2026, is for the combined company before the spin-off, so its figures do not show the company that remains. At that date, Corteva had $2,365 million of cash and $4,875 million of debt: $3,193 million of short-term borrowings, mostly $2,422 million of commercial paper and $600 million under the 364-day credit facility, and $1,682 million of long-term notes. The spin-off moved much of this. On October 1, 2026, Vylor took over $1,439 million of EIDP's $1,600 million of notes due 2030, 2032 and 2033 through exchange offers, so about $161 million of these notes stayed at EIDP. Vylor also issued $1.1 billion of its own notes due 2031 and 2036. On September 24, 2026, EIDP issued $700 million of 6.000% notes due 2036 to repay commercial paper. Corteva has not yet reported a stand-alone balance sheet; the Q3 2026 report on November removed: 11, added: 12, 2026 is the first. PFAS and other legacy costs are the main claim on future cash, beyond the debt. The MOU escrow account for PFAS costs held about $105 million at June 30, 2026. Credit ratings after the spin-off are not confirmed in company filings. As of Jun 30, 2026.
- Checkpoints
- Nov removed: 11, added: 12, 2026: Q3 2026 results: first stand-alone report and outlook. Pending. Watch: Stable Crop Protection prices, a stand-alone outlook with growing EBITDA and a clear plan for dividends and buybacks pass; lower prices from generics or a weak stand-alone outlook fail. Q4 2026 (estimate): Seventh Circuit ruling on the restraining order. Pending. Watch: A stay or reversal of the October 9 order passes; an order that stops dividends and buybacks again fails. 2027 (estimate): States' lawsuit against the spin-off. Pending. Watch: A dismissal or a settlement within the shared PFAS cost limits passes; a ruling that makes Corteva pay large new amounts or unwinds part of the spin-off fails.
- Recent events
- added: Nov 10, 2026: Corteva filed a notice that it cannot file its Q3 2026 Form 10-Q on time. It needs more time for the reporting after the spin-off of Vylor on October 1, 2026, and plans to file within five calendar days after the due date. It expects a larger seasonal loss than in Q3 2025, because of spin-off costs and research spending. It expects to issue its results before the earnings call on November 12, 2026. Oct 15, 2026: Rival FMC cut its Q3 2026 outlook sharply because of weak demand and competition from cheap generic products, and its stock fell more than 33%. Citi said that Corteva is less exposed to generic pressure. Corteva stock fell more than 4% that day. Oct 10, 2026: The federal court in Indiana stayed its temporary restraining order while Corteva and Vylor ask the Seventh Circuit Court of Appeals to stay it during the appeal. On October 9, the order had stopped Corteva and EIDP from paying dividends, buying back shares and selling assets outside normal business. Oct 6, 2026: removed: JPMorgan upgraded Corteva removed: to Overweight from Neutral with a $19 price target, and said that removed: environmental liabilities are the main risk. The stock rose about 11%. Corteva said that it will report Q3 2026 results on November 11, 2026, after the market closes, with a webcast on November 12. Oct 1, 2026: Corteva completed the spin-off of its seed business as Vylor Inc. Shareholders got one Vylor share for each Corteva share. Corteva became a crop protection company led by CEO Luke Kissam. On the same day, 15 states and one sovereign sued in a federal court in Indiana to challenge the spin-off on the basis of PFAS liabilities. Vylor also completed exchange offers, so that most of EIDP's 2030, 2032 and 2033 notes became Vylor notes. Sep 24, 2026: EIDP, Corteva's subsidiary, issued $700 million of 6.000% senior notes due August 15, 2036, to repay commercial paper and for general purposes. Sep 9, 2026: Corteva, EIDP, Chemours and DuPont settled North Carolina's PFAS claims for $455 million over 15 years. Corteva's share is about $66 million. Corteva and DuPont also guarantee Chemours' share of the payments. Jul 30, 2026: Corteva reported Q2 2026 results. Net sales were $6.38 billion, down 1%. Crop Protection sales were $1.85 billion, down 4%, with prices down 4%, and Crop Protection operating EBITDA rose 2% to $342 million. Corteva raised its 2026 outlook for the combined company to operating EBITDA of $4.1 billion to $4.3 billion.